What’s new in the renin-angiotensin system?Structure of angiotensin I-converting enzyme

被引:0
|
作者
E. D. Sturrock
R. Natesh
J. M. van Rooyen
K. R. Acharya
机构
[1] University of Cape Town,Division of Medical Biochemistry, Faculty of Health Sciences
[2] University of Bath,Department of Biology and Biochemistry
关键词
Metallopeptidase; angiotensin I-converting enzyme; angiotensin converting enzyme homologue; neurolysin; carboxypeptidase; structure-based drug design;
D O I
暂无
中图分类号
学科分类号
摘要
Angiotensin-converting enzyme (ACE) is a zinc- and chloride-dependent metallopeptidase that plays a vital role in the metabolism of biologically active peptides. Until recently, much of the inhibitor design and mechanism of action of this ubiquitous enzyme was based on the structures of carboxypeptidase A and thermolysin. When compared to the recently solved structures of the testis isoform of ACE (tACE) and its Drosophila homologue (AnCE), carboxypeptidase A showed little structural homology outside of the active site, while thermolysin revealed significant but less marked overall similarity. The ellipsoid-shaped structure of tACE, which has a preponderance of α-helices, is characterised by a core channel that has a constriction approximately 10 Å from its opening where the zinc-binding active site is located. Comparison of the native protein with the inhibitor-bound form (lisinopril-tACE) does not reveal any striking differences in the conformation of the inhibitor binding site, disfavouring an open and closed configuration. However, the inhibitor complex does provide insights into the network of hydrogen-bonding and ionic interactions in the active site as well as the mechanism of ACE substrate hydrolysis. The three-dimensional structure of ACE now paves the way for the rational design of a new generation of domain-selective ACE inhibitors.
引用
收藏
页码:2677 / 2686
页数:9
相关论文
共 50 条
  • [21] COVID-19, Renin-Angiotensin System, Angiotensin-Converting Enzyme 2, and Nicotine: What is the Interrelation?
    Scholz, Jaqueline Ribeiro
    Cartaxo Queiroga Lopes, Marcelo Antonio
    Kerr Saraiva, Jose Francisco
    Colombo, Fernanda Consolim
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 115 (04) : 708 - 710
  • [22] EXPANDING THE PARADIGM OF THE RENIN-ANGIOTENSIN SYSTEM AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    GREENWALD, L
    BECKER, RC
    AMERICAN HEART JOURNAL, 1994, 128 (05) : 997 - 1009
  • [23] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION VERSUS BLOCKADE OF THE RENIN-ANGIOTENSIN SYSTEM
    BRUNNER, HR
    WAEBER, B
    NUSSBERGER, J
    AMERICAN JOURNAL OF MEDICINE, 1989, 87 (6B): : S15 - S18
  • [24] Angiotensin-converting enzyme 2 expression is not induced by the renin-angiotensin system in the lung
    Baba, Ryuta
    Oki, Kenji
    Itcho, Kiyotaka
    Kobuke, Kazuhiro
    Nagano, Gaku
    Ohno, Haruya
    Yoneda, Masayasu
    Hattori, Noboru
    ERJ OPEN RESEARCH, 2020, 6 (04)
  • [25] THE TISSUE RENIN-ANGIOTENSIN SYSTEM - A TARGET FOR ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    GANTEN, D
    MULLINS, J
    LINDPAINTNER, K
    JOURNAL OF HUMAN HYPERTENSION, 1989, 3 : 63 - 70
  • [26] ANESTHETIC IMPLICATIONS OF THE RENIN-ANGIOTENSIN SYSTEM AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    MIRENDA, JV
    GRISSOM, TE
    ANESTHESIA AND ANALGESIA, 1991, 72 (05): : 667 - 683
  • [27] Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor
    Raizada, Mohan K.
    Paton, Julian F. R.
    EXPERIMENTAL PHYSIOLOGY, 2008, 93 (05) : 517 - 518
  • [28] Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity
    Bloem, LJ
    Manatunga, AK
    Pratt, JH
    HYPERTENSION, 1996, 27 (01) : 62 - 66
  • [29] Angiotensin I-converting enzyme genotype-dependent rise in serum angiotensin I-converting enzyme with exercise.
    Woods, DR
    Sanders, J
    Jones, A
    Gohke, P
    Hurel, S
    Jamshidi, Y
    Hawe, E
    Goldstone, J
    Humphries, S
    Montgomery, H
    CIRCULATION, 2001, 104 (17) : 735 - 735
  • [30] What’s new in the renin-angiotensin system?The angiotensin IV/AT4 receptor
    S. Y. Chai
    R. Fernando
    G. Peck
    S. -Y. Ye
    F. A. O. Mendelsohn
    T. A. Jenkins
    A. L. Albiston
    Cellular and Molecular Life Sciences CMLS, 2004, 61 (21): : 2728 - 2737